$30.30 Million in Sales Expected for IntriCon Co. (IIN) This Quarter

Share on StockTwits

Equities research analysts predict that IntriCon Co. (NASDAQ:IIN) will report sales of $30.30 million for the current quarter, according to Zacks. Two analysts have made estimates for IntriCon’s earnings. IntriCon reported sales of $22.23 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 36.3%. The firm is expected to announce its next earnings report on Monday, February 11th.

On average, analysts expect that IntriCon will report full year sales of $115.93 million for the current year, with estimates ranging from $115.90 million to $115.96 million. For the next financial year, analysts expect that the business will post sales of $138.17 million, with estimates ranging from $136.50 million to $139.84 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that cover IntriCon.

IntriCon (NASDAQ:IIN) last released its quarterly earnings results on Monday, November 5th. The technology company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.02. The business had revenue of $30.13 million during the quarter, compared to analyst estimates of $30.23 million. IntriCon had a return on equity of 13.06% and a net margin of 4.82%.

A number of equities research analysts recently commented on the company. TheStreet raised IntriCon from a “c+” rating to a “b” rating in a research report on Friday, August 31st. Zacks Investment Research raised IntriCon from a “hold” rating to a “buy” rating and set a $39.00 price target for the company in a research report on Wednesday, November 14th. BidaskClub lowered IntriCon from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 13th. B. Riley increased their price target on IntriCon from $62.00 to $73.00 and gave the company a “buy” rating in a research report on Wednesday, August 22nd. Finally, Stifel Nicolaus increased their price target on IntriCon from $65.00 to $70.00 and gave the company a “buy” rating in a research report on Friday, September 21st. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $48.50.

NASDAQ IIN opened at $33.16 on Friday. The firm has a market capitalization of $296.73 million, a P/E ratio of 114.34, a P/E/G ratio of 3.97 and a beta of 0.95. IntriCon has a 12 month low of $16.70 and a 12 month high of $76.80.

A number of large investors have recently made changes to their positions in IIN. First Mercantile Trust Co. bought a new position in IntriCon in the 3rd quarter valued at $159,000. GSA Capital Partners LLP bought a new position in IntriCon in the 2nd quarter valued at $226,000. Rhumbline Advisers bought a new position in IntriCon in the 2nd quarter valued at $232,000. CAPROCK Group Inc. bought a new position in IntriCon in the 3rd quarter valued at $251,000. Finally, Los Angeles Capital Management & Equity Research Inc. bought a new position in IntriCon in the 3rd quarter valued at $270,000. Hedge funds and other institutional investors own 59.51% of the company’s stock.

About IntriCon

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.

Read More: Market Capitalization

Get a free copy of the Zacks research report on IntriCon (IIN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for IntriCon (NASDAQ:IIN)

Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

WARP  Price Reaches $0.0677 on Exchanges
WARP Price Reaches $0.0677 on Exchanges
Zilla Trading Down 14% This Week
Zilla Trading Down 14% This Week
Eagle Pharmaceuticals Inc  Receives Consensus Recommendation of “Hold” from Analysts
Eagle Pharmaceuticals Inc Receives Consensus Recommendation of “Hold” from Analysts
-$0.15 EPS Expected for SUMMIT THERAPEU/S  This Quarter
-$0.15 EPS Expected for SUMMIT THERAPEU/S This Quarter
Chemtrade Logistics Income Fund  Hits New 12-Month Low at $10.19
Chemtrade Logistics Income Fund Hits New 12-Month Low at $10.19
First Cobalt  Reaches New 1-Year Low at $0.19
First Cobalt Reaches New 1-Year Low at $0.19


Leave a Reply

 
© 2006-2018 Zolmax.